iMDx to Participate in NYC Investment Conferences September 8 - 11
iMDx (NASDAQ:IMDX) announced its participation in two upcoming investor conferences in New York City. The company will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8-9, 2025, featuring a company presentation on September 8 at 5:00 pm ET, along with one-on-one meetings.
Additionally, iMDx will participate in the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, 2025, which will consist of one-on-one meetings with investors at the Yale Club of New York City.
[]iMDx (NASDAQ:IMDX) ha annunciato la sua partecipazione a due prossime conferenze per investitori a New York City. La società terrà una presentazione al H.C. Wainwright 27th Annual Global Investment Conference il 8-9 settembre 2025, con una presentazione aziendale l'8 settembre alle 17:00 ET e incontri one-to-one.
Inoltre, iMDx prenderà parte al Lake Street Capital Markets 9th Annual Best Ideas Growth Conference l'11 settembre 2025, svolgendo incontri one-to-one con investitori presso lo Yale Club di New York City.
iMDx (NASDAQ:IMDX) anunció su participación en dos próximas conferencias para inversores en la ciudad de Nueva York. La compañía realizará una presentación en la H.C. Wainwright 27th Annual Global Investment Conference los días 8 y 9 de septiembre de 2025, con una presentación corporativa el 8 de septiembre a las 5:00 pm ET y reuniones individuales.
Además, iMDx participará en la Lake Street Capital Markets 9th Annual Best Ideas Growth Conference el 11 de septiembre de 2025, donde mantendrá reuniones one-to-one con inversores en el Yale Club de la ciudad de Nueva York.
iMDx (NASDAQ:IMDX)는 뉴욕에서 열리는 두 건의 투자자 컨퍼런스에 참가한다고 발표했습니다. 회사는 2025년 9월 8~9일 개최되는 H.C. Wainwright 27th Annual Global Investment Conference에서 2025년 9월 8일 오후 5시(동부시간)에 기업 프레젠테이션을 진행하며 1:1 미팅도 가질 예정입니다.
또한 iMDx는 2025년 9월 11일 개최되는 Lake Street Capital Markets 9th Annual Best Ideas Growth Conference에 참가해 뉴욕 예일 클럽(Yale Club)에서 투자자들과 1:1 미팅을 진행합니다.
iMDx (NASDAQ:IMDX) a annoncé sa participation à deux prochaines conférences investisseurs à New York. La société présentera au H.C. Wainwright 27th Annual Global Investment Conference les 8 et 9 septembre 2025, avec une présentation d'entreprise le 8 septembre à 17h00 ET, ainsi que des réunions individuelles.
Par ailleurs, iMDx participera au Lake Street Capital Markets 9th Annual Best Ideas Growth Conference le 11 septembre 2025, où elle tiendra des réunions one‑to‑one avec des investisseurs au Yale Club de New York City.
iMDx (NASDAQ:IMDX) gab seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York City bekannt. Das Unternehmen wird auf der H.C. Wainwright 27th Annual Global Investment Conference am 8. und 9. September 2025 vertreten sein und hält am 8. September um 17:00 Uhr ET eine Unternehmenspräsentation sowie Einzelgespräche.
Außerdem nimmt iMDx am Lake Street Capital Markets 9th Annual Best Ideas Growth Conference am 11. September 2025 teil, wo One‑on‑One‑Meetings mit Investoren im Yale Club in New York City stattfinden werden.
- None.
- None.
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can be found below:
Event: H.C. Wainwright 27th Annual Global Investment Conference
Date: September 8 – 9, 2025
Location: In-person at the Lotte New York Palace Hotel and virtual
Format: Company presentation on Monday, September 8 at 5:00 pm ET, and one-on-one meetings
Link to live and replay: Click here
Event: Lake Street Capital Markets 9th Annual Best Ideas Growth Conference (BIG9)
Date: September 11, 2025
Location: In-person at the Yale Club of New York City
Format: One-on-one meetings
Investors wishing to participate are encouraged to reach out to their H.C. Wainwright or Lake Street sales representatives.
About Insight Molecular Diagnostics, Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.Insight Molecular Diagnostics.com/ for more information.
GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.
Investor Contact:
Doug Farrell
LifeSci Advisors LLC
dfarrell@lifesciadvisors.com
FAQ
When is iMDx presenting at the H.C. Wainwright Global Investment Conference 2025?
Where will the Lake Street Capital Markets BIG9 Conference for iMDx take place?
How can investors participate in meetings with iMDx at these conferences?
What format will iMDx's participation take at these investment conferences?
